News

The first-ever ITCC Scientific Days concluded with big success!  The Innovative Therapies for Children with Cancer (ITCC) conference brought together leading international experts and researchers in pediatric oncology to discuss the latest advancements, challenges, and opportunities in understanding and treating pediatric cancers.  Exciting breakthroughs were discussed, including a novel treatment approach for high-grade gliomas that […]

Prof. Florian Grebien, PhD, is eager to understand why some childhood leukemias show poor treatment response and how this can be tackled. To this end, he is now establishing his own team at St. Anna Children’s Cancer Research Institute (St. Anna CCRI). “Prof. Grebien is an outstanding researcher. We have followed his scientific achievements for many years and are very pleased to have been able to recruit him as a Principal Investigator to St. Anna CCRI,” says Prof. Kaan Boztug, MD, Scientific Director of St. Anna CCRI.

Neuroblastoma Dialogue at ANR Meeting in Amsterdam (Vienna, 26.05.2023) At last week’s Advances in Neuroblastoma Research (ANR) Meeting in Amsterdam, St. Anna CCRI had a strong presence contributing with remarkable talks and posters. Florian Halbritter captivated the audience with his insightful talk on their study titled “Neuroblastoma-associated chromosomal aberrations drive cell identity loss in human neural

Top Talk of the API Conference (Vienna, 19.05.2023) Artem Kalinichenko won the prize for the best talk at the recent API in Germany. His presentation on a genome-wide CRISPR screening approach to identify and study key factors essential for human lymphocyte function stood out for its groundbreaking insights. API (Arbeitsgemeinschaft Pädiatrische Immunologie) is an esteemed

“Children are our future. It’s really important to take care of them.” (Vienna, 11.5.2023) Maria Happel in brief: Why she supports the St. Anna Children’s Cancer Research Institute, how she deals with criticism, and what acting in plays has to do with healing the soul. Under the motto of our 35th anniversary “Reaching for the stars”, we

CLLS 2023 Symposium: Advancements in Childhood Leukemia and Lymphoma Research (Vienna, 07.05.2023) The 13th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS) unfolded in Valencia, where St. Anna CCRI, Labdia, and St. Anna Children’s Hospital actively participated. CLLS is a pivotal platform for fellows, researchers, and junior faculty to share groundbreaking insights into malignant hematological malignancies,

Natural Killer Cell Symposium in Krems (Krems, 04.05.2023) The NK Cell Symposium in Krems was a pivotal gathering spotlighting the role of natural killer (NK) cells in cancer immunotherapy. Researchers from the St. Anna CCRI and other institutions shared their latest findings, emphasizing NK cells’ potential as a powerful tool in combating cancer. The NK

(Vienna, 29.4.2023) Today is International Day of Immunology – a day to raise awareness for the importance of immunology. A recent study from St. Anna Children’s Cancer Research Institute reveals the association between an impaired immune system and the susceptibility to viral infections and cancer in a young patient.

From Now to NEXT: AI-Driven Neuroblastoma Diagnostics (Vienna, 25.04.2023) A follow-up project, aiming to address the urgent need for advanced diagnostic tools in ultra-high-risk pediatric cancer research was funded by the WWTF NEXT Call. By developing a web-based app, Sabine Taschner-Mandl seeks to empower diagnostic laboratories to conduct tests independently, enhancing the precision and speed

That was the first Panel Discussion – “Reaching for the Stars – We & Science!” (Vienna, 25.04.2023) The new discussion series “Reaching for the Stars – We & Science!” in cooperation with the Wiener Zeitung started last Tuesday with an inspiring exchange between St. Anna CCRI Principal Investigator Caroline Hutter and Science Buster Martin Moder.

Panel Discussion: “Reaching for the Stars – We & Science”  in cooperation with the Wiener Zeitung. Making the impossible possible – and thus reaching for the stars. This is the claim that St. Anna Children’s Cancer Research Institute has successfully realized in its 35 years of existence. With the clear mission of enabling children with

Instand–NGS4P General Assembly (Vienna, 30.03.2023) St. Anna CCRI was recognized in the January edition of the Organization of European Cancer Institute’s Newsletter. This newsletter featured St. Anna CCRI as the exclusive childhood oncology partner in the Instand-NGS4P project. Leveraging this early recognition, the team, led by the Scientific Director Kaan Boztug and Ruth Ladenstein, actively

A combination therapy against childhood bone cancer is efficient in living organisms: if the tumor is transplanted into fish larvae and treated with certain drugs, it shrinks significantly or disappears completely. However, the journey will still take a while before these drugs can be applied in children, say Martin Distel, PhD, from St. Anna Children’s Cancer Research Institute and co-authors. The results were published in the journal Cancer Letters.

Today is RARE DISEASE DAY: We are committed to rare disease research!  (Vienna, 28.02.2023) 300 million people worldwide suffer from rare diseases. Today is Rare Disease Day – a day to raise awareness for precisely these diseases. Together with the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, CeMM Research Center for Molecular Medicine of